Statement from the regional councilor, Fabiano Amati.
“Finally. After a thousand ordeals, very harsh controversies and the collective dismissal, decided by the San Raffaele Foundation, of the healthcare and non-healthcare staff of the Ceglie Messapica Rehabilitation Centre, the ASL of Brindisi today published the recruitment notices, previously on a fixed-term basis and then for an indefinite period, of the staff necessary to guarantee the public management of the Centre. Thus begins a new era and I gratefully thank the majority of the staff of the Rehabilitation Centre, who without any fear stood alongside the public administration to achieve this very important result, supporting me even in the darkest moments.
“I thank the President of the Region Michele Emiliano who in recent months has never abandoned his desire to achieve the result and encouraged me throughout the battle.
“I thank the DG of the ASL of Brindisi Maurizio De Nuccio and all the company managers.
“I thank the regional managers who have collaborated in recent months to better revive the initiative – Vito Montanaro, Mauro Nicastro, Vito Carbone and Antonella Caroli – and through them all the officials.
“I thank the lawyers of the Rossana Lanza Region and Paolo Scagliola, and the lawyers of the ASL Michele Dionigi and Gabriele Garzia.”
AC, Mammographs and Large Machines. Amati: “The law on information flows has been violated and therefore we do not know the number of obsolescent machines in use, with unjust diagnosis consequences”
Statement from the president of the Regional Budget and Planning Commission, Fabiano Amati.
“We do not know the total number of large machines we have (CT scans, PET scans, MRI scans, linear accelerators, mammographs, etc.) in the public sector, among accredited public service workers and in the non-accredited private sector; we do not know their possible obsolescence and therefore the need to dispose of them; we are not able to calculate any glaring inequalities in the different diagnoses. A very serious matter on which we began an in-depth analysis today, under the wise and competent guidance of Concetta Ladalardo and Elisabetta Graps, managers of the Region and ARESS respectively. At present, a total of 562 active devices are registered, of which 284 public and 278 private, but the registration of flows is patchy, i.e. with differences between ASL and ASL.
“It appears, essentially, an inaccurate flow and therefore a considerable difficulty in evaluation and a high obsolescence. It must be kept in mind that a technology is considered reliable if it does not exceed the time range of 5 years for 60% of the technological park, that between 6 and 10 years for 30% of the park and that over 10 years for 10% of the park.
“Next Monday we will hear from all the directors of the clinical areas of the healthcare companies and the IRCCS to encourage the updating of data on information flows and therefore the consequent decommissioning of obsolete machines. It is a question of justice and equity.”
Suitable renewable areas. Amati: “Environmental safety is a prevailing interest. The council’s commitment to adopting the bill by next week is good”
Press release from regional councilor Fabiano Amati.
“Environmental safety is a prevailing interest of our Region and therefore we have the duty to add the new 7 GW to our energy production capacity from renewable sources.
“In this sense, today’s hearing produced positive news and I approve the commitment of the Regional Council to adopt the bill by next week’s deadline, so as to allow its examination in the Chamber before the budget session, avoiding the risk of administration.
“The fact that all conflicts have been reduced, many of a cultural nature and in conflict with environmental safety, starting with those that reconstruct landscape protection in a largely discretionary and poorly typified evaluation process, gives hope for respect for the timing and of the objectives.
“I thank the directors of the Economic Development and Environment and Landscape Departments Gianna Berlingerio and Paolo Garofoli, as well as the official of the territorial services coordination section Grazia Nardelli.”
Brain tumor. Amati: “There is an expensive device outside the LEAs that extends life by about 4 months; Is it right to deny it? It’s a lacerating question that we are delving into. Postponed until next Monday.”
Statement by the president of the Regional Budget and Planning Commission, Fabiano Amati.
“There is a device (Optune) capable of extending the lives of patients suffering from glioblastoma, an aggressive brain tumor, which costs 21 thousand euros, plus VAT, and which currently cannot be provided free of charge because it does not included in the Essential Levels of Assistance. This device, consisting of a helmet weighing 1 kg to be worn for 18 hours a day and on a completely shaved head, provides an advantage of at least 4 months of additional life.
“It is clear that there would be various administrative ways to overcome the extra LEA limit of the device, but on this point the very competent evaluation offered by the clinicians of the IRCCS Giovanni Paolo II Nicola Silvestris, Loredana Palermo and Oronzo Brunetti, by the representative of the ARESS Elisabetta Graps and the regional manager responsible for the devices Paolo Stella.
“The aspects that have been clarified today concern the function of the device, the survival free from disease progression (from 16 to 21 months) and the tolerability in terms of toxicity but not discomfort. On all this, obviously, there are also evaluations on the cost -effectiveness. The parameter usually used on this aspect is the maximum limit of 60 thousand euros per year of life gained, which in the case of the device in question would instead skyrocket to 500 thousand euros per year earned, i.e. well beyond any limit.
“It is clear that the prescription of the device cannot be decided only on the basis of the price parameter, and a remodulation of this is hoped for with the manufacturing company, but on the basis of a purely clinical evaluation carried out by medical specialists and agreed with the patients We will delve deeper into each evaluation on this point next Monday.
However, the fact remains that the fight against disease and even technological innovation are capable of opening up highly lacerating questions for science and conscience, to which the response of clinicians and politicians can never consist in avoiding think about it and therefore leave the heavy burden on the shoulders of the sick and patients.”
